Sirtuin Enzymes within the Spotlight

SIRT6 in Complex With Nucleosome

Revealed: The Secrets our Clients Used to Earn $3 Billion

New photos of the SIRT6 sirtuin enzyme—which regulates ageing and different metabolic processes—assist clarify the way it is ready to entry genetic materials inside the cell. This cryo-electron microscopy map reveals the enzyme in advanced with the nucleosome, a tightly packed advanced of DNA and proteins referred to as histones. Credit: Song Tan Lab, Penn State

Penn State researchers have revealed how sirtuin enzymes work together with nucleosomes to control ageing and metabolic processes. Their findings, utilizing cryo-electron microscopy, might inform drug discovery efforts focusing on sirtuins for biomedical functions.

New scientific analysis offers perception into how an enzyme that helps regulate ageing and different metabolic processes accesses our genetic materials to modulate gene expression inside the cell. A group led by Penn State researchers has produced photos of a sirtuin enzyme sure to a nucleosome—a tightly packed advanced of DNA and proteins called histones—showing how the enzyme navigates the nucleosome complex to access both DNA and histone proteins and clarifying how it functions in humans and other animals.

A paper describing the results was published on April 14 in the journal Science Advances.

Sirtuins are a type of enzyme found in organisms ranging from bacteria to humans that play important roles in aging, sensing DNA damage, and suppressing tumors in various cancers. Because of these varied roles, pharmaceutical companies are exploring their potential for biomedical applications. Much effort has focused on the ability of some sirtuins to decrease gene expression by removing a chemical flag from histone proteins.

“In our cells, DNA is not naked like we see it in textbooks; it is spooled around proteins called histones within a large complex called the nucleosome,” said Song Tan, Verne M. Willaman Professor of Molecular Biology at Penn State and an author of the paper. “This packaging can also contribute signals for turning on or turning off genes: Adding an ‘acetyl’ chemical flag to the histone packaging material turns on a gene, while removing the acetyl flag turns the gene off. Sirtuins can silence gene activity by removing the acetyl flag from histones packaged into nucleosomes. Understanding how sirtuins interact with the nucleosome to remove this flag could inform future drug discovery efforts.”

Previous studies have focused on how sirtuins interact with short segments of histones in isolation, in part because such histone “tail” peptides are much easier to work with in the lab. According to Tan, the nucleosome is a hundred times larger than typical histone peptides used in these studies and are consequently much more complicated to work with.

“We have visualized a sirtuin enzyme called SIRT6 on its physiologically relevant substrate—the entire nucleosome,” said Jean-Paul Armache, assistant professor of biochemistry and molecular biology at Penn State and an author of the paper. “And we found that SIRT6 interacts with multiple parts of the nucleosome, not only the histone where the acetyl flag is to be modified.”

Using a powerful type of imaging called cryo-electron microscopy with instruments at the Penn State Cryo-Electron Microscopy Facility, the National Cancer Institute, and the Pacific Northwest Cryo-EM Center, the researchers identified how SIRT6 positions itself on the nucleosome in order to remove an acetyl group from the K9 position on the histone called H3. Following up with biochemical experiments—in collaboration with the lab of Craig Peterson at the University of Massachusetts Chan Medical School—helped confirm their results.

The researchers found that SIRT6 binds to the nucleosome using a type of connection called an “arginine anchor.” This type of binding—described by Tan’s lab in 2014—is used by a variety of proteins that target a particularly acidic patch on the nucleosome’s surface. In this case, a structural feature of SIRT6 called an extended loop nestles into a divot in the acidic patch, somewhat like a pipe sitting in a ditch.

“The arginine anchor is a common paradigm for how many chromatin proteins interact with the nucleosome,” said Tan. “When we mutated the SIRT6 arginine anchor, the activity at the K9 position was severely affected, supporting a critical role for the SIRT6’s arginine anchor. Surprisingly, this mutation also impacted SIRT6’s enzymatic activity at a different position, K56, located much further away.”

Instead of SIRT6 binding to the nucleosome in two different ways to access the two different histone positions, it is possible that SIRT6 binds to access K9 in a way that might also provide access to K56.

“SIRT6 binds to a partially unwrapped nucleosome, with DNA displaced from the end of the nucleosome,” said Armache. “This exposes the K56 position, and it is possible that SIRT6 could essentially lean down to reach that position. We would like to validate this hypothesis in the future. We also hope to explore how SIRT6 works alongside other enzymes and to better understand its role in the response to DNA damage.”

Reference: “Cryo-EM structure of the human Sirtuin 6–nucleosome complex” by Un Seng Chio, Othman Rechiche, Alysia R. Bryll, Jiang Zhu, Erik M. Leith, Jessica L. Feldman, Craig L. Peterson, Song Tan and Jean-Paul Armache, 14 April 2023, Science Advances.
DOI: 10.1126/sciadv.adf7586

In addition to Tan, Armache, and Peterson, the research team at Penn State includes postdoctoral scholars Un Seng Chio, Othman Rechiche, and Jiang Zhu and graduate student Erik Leith. The research team at the UMass Chan Medical School also includes Alysia Bryll and Jessica Feldman. This research was supported by the U.S. National Institutes of Health and the Pennsylvania Department of Health using Tobacco CURE funds.